Logo-npj

Original

1. Pathological patterns of mesangioproliferative glomerulonephritis seen at a tertiary care center
Ghadeer A. Mokhtar*, Sawsan Jalalah, Shabnum Sultana
J Nephropharmacol. 2014;3(2): 33-37.
Article
PDF
XML
Cited By:
Photoclinic

2. Erysipelas-associated glomerulonephritis; a diagnostic puzzle
Mohammad-Reza Ardalan*
J Nephropharmacol. 2014;3(2): 47-48.
Article
PDF
XML
Cited By:
Epidemiology and Prevention

3. Evaluation and management of children with acute kidney injury in emergency department
Abdolghader Pakniyat, Parsa Yousefichaijan*
J Nephropharmacol. 2015;4(2): 83-84.
Article
PDF
XML
Cited By:
Case Report

4. Dual pathology as a cause of proteinuria in the post-transplant period; report of a case
Rohit Tewari*, Satish Mendonca, Vijay Nijhawan
J Nephropharmacol. 2016;5(1): 66-68.
Article
PDF
XML
Cited By:
Original

5. A study of primary glomerular diseases in adults; clinical, histopathological and immunofluorescence correlations
Ananta Satya Narayana Modugumudi, Phaneendra Bobbidi Venkata, Siva Kumar Vishnu Bottla, Radhika Kottu*, Rukmangadha Nandyala, Rashmi Patnayak, Amit Kumar Chowhan, Lakshmi Amancharla Yadgiri
J Nephropharmacol. 2016;5(2): 91-97.
PMCID: PMC5297573     PMID: 28197510    
Article
PDF
XML
Cited By:
2
Commentary

6. C4d in IgA nephropathy: a marker sans boundaries
Muhammed Mubarak*
J Nephropharmacol. 2016;5(2): 102-103.
PMCID: PMC5297560     PMID: 28197512    
Article
PDF
XML
Cited By:
0
Commentary

7. Primary glomerular disease in adults: pattern over decades,interpretation across the globe
Rubina Naqvi*
J Nephropharmacol. 2016;5(2): 108-109.
PMCID: PMC5297563     PMID: 28197515    
Article
PDF
XML
Cited By:
0
Original

8. Spectrum of renal biopsies; a three-year data from a tertiary care centre of eastern India
Chetan Mahajan ORCID, Vaibhav Tiwari ORCID, Smita Subhash Divyaveer* ORCID, Malagouda R Patil ORCID, Avinandan Banerjee ORCID, Vishnuvardhan Bagur, Umesh Dubey, Koushik Battacharjee, Sandeep Saini, Tanima Das Bhattacharya ORCID, Arpita Raychaudhury ORCID, Sanjay Dasgupta ORCID, Dipankar Sarkar ORCID, Anila Abraham Kurien ORCID, Rajendra Pandey
J Nephropharmacol. 2020;9(2): e20. doi: 10.34172/npj.2020.20
Scopus ID: 85085942814    
Article
PDF
Suppl 1
XML
Cited By:
3
1
News and Views

9. Glomerulonephritis associated with SARS-CoV-2 infection
Mohsen Akhavan Sepahi* ORCID, Bhaskar VKS Lakkakula ORCID, Bijan Roshan ORCID, Banafsheh Yalameha ORCID
J Nephropharmacol. 2021;10(1): e07. doi: 10.34172/npj.2021.07
Scopus ID: 85090690110    
Article
PDF
XML
Cited By:
0
0
Review

10. Immune-related adverse kidney events by immune checkpoint inhibitors; a narrative review on current studies
Tella Sadighpour* ORCID, Celeste Cagnazzo ORCID, Shahrzad Alimohammadi ORCID, Anahita Emami ORCID, Azadeh Khayyat, Mohammad Ali EsmaeilPour
J Nephropharmacol. 2021;10(2): e22. doi: 10.34172/npj.2021.22
Scopus ID: 85111448122    
Article
PDF
XML
Cited By:
0
0

Review

11. Recurrence of rare disease after kidney transplant
Farahnoosh Farnood ORCID, Seyyedeh Mina Hejazian ORCID, Kamal Boostani ORCID, Alireza Mardomi ORCID, Mohammadreza Ardalan* ORCID
J Nephropharmacol. 2023;12(1): e10519. doi: 10.34172/npj.2022.10519
Scopus ID: 85146791012    
Article
PDF
XML
Cited By:
0
0
Mini-Review

12. Targeted-release budesonide in immunoglobulin A nephropathy; a mini-review
Shiva Toumaj ORCID, Shahrzad Alimohammadi ORCID, Maryam Ghasemi ORCID, Shokouh Shayanpour* ORCID
J Nephropharmacol. 2023;12(2): e10605. doi: 10.34172/npj.2023.10605
Scopus ID: 85162004368    
Article
PDF
XML
Cited By:
0
0
Mini Review

13. Nephrotoxicity of checkpoint inhibitors; a current challenge
Samaneh Zandifar ORCID, Mahshid Imankhan ORCID, Padideh Daneii ORCID, Ali Azarpey* ORCID, Leila Alem* ORCID
J Nephropharmacol. 2024;13(1): e10641. doi: 10.34172/npj.2023.10641
Article
PDF
XML
Cited By: